Sysmex America, Inc. Appoints Ramon Simon-Lopez, M.D. Medical Director

LINCOLNSHIRE, Ill., May 13, 2015 /PRNewswire/ -- Sysmex America, Inc., a global leader in medical diagnostic testing equipment and information systems technology, announces today that Ramon Simon-Lopez, M.D. has been appointed Medical Director. In his role, Dr. Simon-Lopez will be responsible for pre-market scientific and applications-based research activities for all specialties, including hematology, urinalysis, flow cytometry and hemostasis. He will work closely with Sysmex Corporation helping to increase the clinical value of Sysmex instruments.

"As a highly accomplished medical and scientific leader with extensive expertise in laboratory hematology and information systems, Dr. Simon-Lopez is exceptionally well suited for the Medical Director position," said John Kershaw, President and Chief Executive Officer, Sysmex America, Inc. "No doubt, his leadership will greatly influence our R&D process and help Sysmex continue to innovate in diagnostics technology."

Dr. Simon-Lopez is an expert in hematology with considerable knowledge in medical research and scientific studies. Previously, he served as European Scientific Manager and Global Scientific Director at Beckman Coulter.

Prior to that, Dr. Simon-Lopez ran a private practice in Internal Medicine and Hematology. He also served as Hematology Scientific Manager for Isaza S.A. and held medical positions in Hematology at the La Alianza Clinic and Hospital Clinic of Barcelona in Spain.

Dr. Simon-Lopez holds several patents and is a published author of scientific papers with over 100 articles and communications attributed to his name. He is a member of the International Council for Standardization in Hematology (ICSH) and serves as a reviewer for the International Journal of Laboratory Hematology (IJLH). Dr. Simon-Lopez earned his graduate degree in medicine from the University of Barcelona.

About Sysmex America, Inc.

Sysmex America, Inc., in Lincolnshire, Illinois, the U.S. headquarters of Sysmex Corporation (Kobe, Japan), is a trusted world leader in clinical laboratory systemization and solutions that optimize the clinical utility, operational efficiency and financial performance of the lab. Sysmex America distributes and supports a diversified portfolio of best-in-class automated in vitro diagnostic hematology, coagulation and urinalysis analyzers, reagents and information systems for laboratories and healthcare facilities throughout the Western Hemisphere. The Company's unwavering commitment to clinical excellence and technological innovation is reflected in the Sysmex brand and its distinguished heritage of unsurpassed reliability. Sysmex is reshaping the healthcare of tomorrow at the clinical laboratory level by transcending the boundaries of diagnostic science and serving as the pulse of reliable, accountable care. For more information about Sysmex, please visit www.sysmex.com/us.

Logo - http://photos.prnewswire.com/prnh/20130612/CG30721LOGO-b

Suggested Articles

After beating the standard of care at keeping testosterone levels down, Myovant's prostate cancer drug fell short in patients with metastatic disease.

A Mount Sinai-led team found that immune cells in the brain protect it from abnormal activation that can lead to behavioral problems.

Results from the small cohort suggest the vaccine triggers comparable immune responses in younger and older adults.